Abstract Phosphatidylinositol-4,5-bisphosphate [PI(4,5)P 2 or PIP 2 ] is a direct modulator of a diverse array of proteins in eukaryotic cells. The functional integrity of transmembrane proteins, such as ion channels and transporters, is critically dependent on specific interactions with PIP 2 and other phosphoinositides. Here, we report a novel requirement for PIP 2 in the activation of the epidermal growth factor receptor (EGFR). Down-regulation of PIP 2 levels either via pharmacological inhibition of PI kinase activity, or via manipulation of the levels of the lipid kinase PIP5K1α and the lipid phosphatase synaptojanin, reduced EGFR tyrosine phosphorylation, whereas up-regulation of PIP 2 levels via overexpression of PIP5K1α had the opposite effect. A cluster of positively charged residues in the juxtamembrane domain (basic JD) of EGFR is likely to mediate binding of EGFR to PIP 2 and PIP 2 -dependent regulation of EGFR activation. A peptide mimicking the EGFR juxtamembrane domain that was assayed by surface plasmon resonance displayed strong binding to PIP 2 . Neutralization of positively charged amino acids abolished EGFR/PIP 2 interaction in the context of this peptide and down-regulated epidermal growth factor (EGF)-induced EGFR autophosphorylation and EGF-induced EGFR signaling to ion channels in the context of the full-length receptor. These results suggest that EGFR activation and downstream signaling depend on interactions of EGFR with PIP 2 and point to the basic JD's critical involvement in these interactions. The addition of this very different class of membrane proteins to ion channels and transporters suggests that PIP 2 may serve as a general modulator of the activity of many diverse eukaryotic transmembrane proteins through their basic JDs.
Introduction
Phosphatidylinositol-4,5-bisphosphate [PI(4,5)P 2 (or PIP 2 )] is a phospholipid of pivotal importance to eukaryotic memElectronic supplementary material The online version of this article (doi:10.1007/s00424-010-0904-3) contains supplementary material, which is available to authorised users.
branes. Receptor-induced hydrolysis of PIP 2 by phospholipase C (PLC) into the second messengers diacylglycerol and inositol triphosphate and receptor-mediated phosphorylation of PIP 2 by phosphatidylinositol 3-kinase (PI3K) into PIP3 initiate two vital receptor-regulated signaling pathways (the PLC and PI3K pathways, respectively), whereas PIP 2 itself can bind to an increasing number of effectors, influencing a variety of cellular processes [5, 7] . PIP 2 has been implicated in cytoskeletal organization [14, 51] , membrane trafficking and vesicle exocytosis, and endocytosis and motility [24, 47] . Decreased nerve terminal PIP 2 levels lead to synaptic defects and early postnatal lethality in mice [6] . Most ion channels and transporters tested show dependence of their activities on levels of plasma membrane PIP 2 [42] . Examples of PIP 2 -dependent ion channels include K + channels, such as the inward rectifiers (Kir) [18] and the M-current [43, 52] , voltage-gated Ca 2+ channels [49] , TRP channels [3, 35] , and NMDA receptors [23, 26] (for a recent review, see Logothetis et al. [20] ). Extracellular signals acting through G protein-coupled or growth factor receptors that can cause PIP 2 hydrolysis, dramatically affect transporter function and ion channel gating [42] . Structure-function studies aiming to identify the channel sites of interaction with PIP 2 have revealed a hotspot of interactions in a highly basic region of the juxtamembrane domain (JD) of the protein immediately proximal to the membrane.
The epidermal growth factor receptor (EGFR, also known as ErbB1) is a member of the receptor tyrosine kinase (RTK) family. The EGFR and other ErbB RTKs play crucial roles in cell growth, survival, proliferation, and differentiation as well as carcinogenesis. Mice lacking EGFR die shortly after birth due to multi-organ failure, developing skin, lung, pancreas, and gastrointestinal tract abnormalities and progressive neurodegeneration [27, 40] . Binding of EGF induces dimerization of EGFR monomers, followed by trans-autophosphorylation of key tyrosine residues on the EGFR intracellular tails, which upregulates their intrinsic RTK activity [38] . The EGFR is functionally coupled to the turnover of PIP 2 , as direct tyrosine phosphorylation of phospholipase Cγ by activated EGFR triggers PIP 2 hydrolysis to IP 3 and diacylglycerol, which leads to Ca 2+ mobilization and protein kinase C (PKC) activation, respectively [32, 33] .
Although studies of effects of EGF on excitable membranes are expanding, the mechanism that links EGF stimulation to the trans-autophosphorylation and activation of the receptor remains elusive. It is however increasingly appreciated that the JD of EGFR plays a central role in the activation process [1, 15, 25, 31, 44] . Recent structural studies coupled with mutagenesis have provided compelling evidence that the distal JD (termed JM-B or JMAD) stabilizes the activated dimmer via interactions revealed by crystal structures [25, 44] . Yet, the precise role of the proximal JD (here referred to as the basic JD) is not clear [44] . Here we use a variety of approaches (i.e., biochemical, genetic, and electrophysiological) to show that EGFR phosphorylation and downstream signaling to ion channels depend on receptor interactions with PIP 2 . A cluster of positively charged residues in the basic JD of EGFR is likely to be involved in the binding of EGFR to PIP 2 . Neutralization mutations of the positively charged amino acids abolishes EGFR/PIP 2 interaction, suppresses EGF-induced EGFR auto-phosphorylation and down-regulates EGF-induced EGFR signaling to ion channels. Furthermore, pharmacological or genetic down-regulation of PIP 2 levels decreases EGF-induced receptor phosphorylation, whereas upregulation of PIP 2 levels augments it. Since EGFR activation leads to hydrolysis of PIP 2 , we propose that its functional dependence on PIP 2 can serve as a mechanism of self-desensitization.
Materials and methods

Chemicals, antibodies
Wortmannin was purchased from Sigma and antibodies were purchased from Cell Signaling Technologies (EGFR P-Y992 ), Santa Cruz Biotechnologies (EGFR, β-tubulin), Millipore (anti phospho-Tyrosine 4 G10) and Genetex (PIP5KIα).
Surface plasmon resonance
A Biacore 2000 optical biosensor was used together with Biacore streptavidin-coated (SA) sensor chips and BIA Evaluation software. The SA chips were washed and equilibrated in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) or phosphate-buffered saline (PBS) buffer (pH 8.0, 20 μl/min), Soluble biotinylated C6 PIP 2 was purchased from Echelon and 1-10 mM stocks were prepared in water. After brief sonication, biotinylated PIP 2 was immobilized by consecutive injections (3 μl/min, 90 min) until an approximate increase of 300 resonance units was achieved. Peptides were introduced at five serial dilutions in Biacore buffer (1 mM DTT, 2.5 mM MgCl 2 , 20 mM HEPES, 1 mM EDTA, 150 mM NaCl, 0.005% P20) in 60-100 μl injection volumes and at a flow rate of 20 μl/min. Binding was measured at 25°C for 5 min, followed by 15 min of dissociation. Then 1 min of wash with regeneration buffer was performed (1 M NaCl, 12.5 mM NaOH). The whole process was then repeated three times for each dilution sample. Sensorgram data were analyzed with the BIA evaluation kinetics package and the equilibrium affinity constant was calculated. Peptides were at least 95% pure (Biosynthesis). cDNAs, mutagenesis, cRNAs Human EGFR, Kir3.4*(S143T) (the Kir3.4 mutant that yields large homomeric currents), synaptojanin (a gift from Dr. Pietro DeCamilli, Yale University, CT) and PI(5)P kinase (a gift from Drs. Show-Ling Shyng and Colin Nichols, Washington University, MO) cDNAs were subcloned into the high-expression vector pGEMsH [34] . Point mutations were introduced using the Quikchange mutagenesis kit (Stratagene) and custom primers with nucleotide mismatch (Invitrogen) and were confirmed by sequencing. cRNAs were transcribed using an in vitro transcription kit with the T7 promoter (Ambion).
Oocyte preparation and injections
Stage V or VI Xenopus laevis oocytes were surgically removed from ovaries and digested with collagenase using standard methods [19] . Oocytes were kept for 2-4 days at 17°C. Oocytes were injected (50 nl/oocyte) with full-length wild-type or mutant EGFR (5 ng), Kir3.4*(S143T) (2 ng), synaptojanin (10 ng) or PI(5)P kinase (10 ng) cRNAs, and analyzed 2-3 days post injection.
Electrophysiological recordings
Electrophysiological recordings were performed 2-4 days after injection using a DAGAN two-electrode voltage-clamp amplifier and currents were obtained with a square pulse protocol. For the measurements of calcium-activated chloride currents, the bath solution (Ringer's) contained (in mM): 115 NaCl, 2.5 KCl, 1.8 BaCl 2 , and 10 HEPES, pH 7.2. For the experiments with Kir3.4 (we used the S143T mutant that yields large homomeric currents) the bath solution (high potassium, HK) contained (in mM): 91 KCl, 1 NaCl, 1 MgCl 2 , and 5 HEPES/KOH. HK supplied with 3-4 mM BaCl 2 was added at the end of the experiment to block potassium currents and obtain a measurement of the leak current. Rapid solution exchange was achieved with a gravity flow perfusion system converging on a 6 μl oocyte chamber engineered in our laboratory from inert materials.
Western immunoblotting
Equal numbers of 25-50 oocytes for each experimental group were stimulated with EGF (100 ng/ml for 10 min) in PBS supplied with phosphatase inhibitors (10 mM NaVO 4 , 10 mM NaF) and directly homogenized in 5 mM Tris-HCl pH 8.0, 1 mM EDTA, 1 mM EGTA containing 10 mM NaVO 4 , 10 mM NaF and complete protease inhibitor cocktail (Roche). For preparation of the membrane fraction, homogenates were centrifuged for 5 min at 5,000 RPM (4°C) and supernatants were subsequently ultracentrifuged at 100,000×g for 40 min at 4°C in a Beckman Maxima Ultracentrifuge. The pellets were re-suspended with a suitable volume of lysis buffer (0.5-1 μl per oocyte), mixed with sodium dodecyl sulfate (SDS)-PAGE loading buffer, boiled for 10 min and analyzed by Western blotting. Total EGFR levels in the samples were determined either on the same membrane used for phosphorylated EGFR (after stripping and re-probing) or on duplicate membranes. For the statistical analysis, densitometric data were normalized for EGFR expression levels and expressed relative to the normalized value of the control in each experiment. Results are expressed as mean±SEM. Statistical significance was determined with a Student's t test.
HeLa cell and siRNA experiments HeLa cells were plated in 60-mm dishes and serum starved with 0.5% fetal bovine serum for 16 h in the presence of 100 nM or 15 μM Wortmannin, or vehicle DMSO. After 16 h, the cells were stimulated with 100 ng/ml EGF for 10 min, then lysed in 1%SDS solubilization buffer in the presence of protease (Roche) and phosphatase (Sigma) inhibitor cocktails. 50 μg of lysate was analyzed by Western immunoblotting (WB) as described above. For siRNA transfection, HeLa cells were plated and transfected according to the manufacturer's (NeoFx kit, Ambion) instructions, using siRNA targeting exons 9,10 of human PIP5KIα in a final concentration of 100 nM in OPTIMEM medium. Cells were incubated for 48-72 h before assaying.
Results
Mutations of EGFR closest to the membrane interface suppress its auto-phosphorylation and downstream signaling
McLaughlin et al. [25] used fluorescence resonance energy transfer to show that a peptide made of the EGFR JD could sequester PIP 2 . Using surface plasmon resonance (SPR) as the assay to confirm EGFR/PIP 2 interaction, we reproduced these results, showing that a peptide mimicking the EGFR juxtamembrane domain (region 645-662) displayed strong binding to PIP 2 (Fig. 1b, top panel) . Inspection of the JD of EGFR, as well as other RTKs, shows the presence of a cluster of positively charged residues that alternate with hydrophobic residues (Fig. 1a) , The pattern of basic and hydrophobic residues is reminiscent of the basic JDs of most ion channels [8, 13, 21, 35, 52] , as well as the PIP 2 -binding motifs of some cytoskeletal proteins [51] . Neutralization of the first eight positively charged amino acids abolished EGFR/PIP 2 interaction in the SPR assay, further highlighting the importance of the eight positively charged amino acids within the 645-662 region for EGFR/PIP 2 interaction (Fig. 1b, middle panel) . Interestingly, this positively charged region of the EGFR juxtamembrane domain has been shown to be of critical importance for EGFR activation. Deletion of the amino acids between 645 and 657 of the EGFR JD region has been shown to abolish receptor dimerization and autophosphorylation [1] , while a mutant EGFR bearing the same eight mutations as the ones used in our SPR experiments (Fig. 1b, middle panel) has previously been shown to lack tyrosine phosphorylation when heterologously expressed [50] . In view of these earlier reports, our data raise the possibility that EGFR activation and downstream signaling depend on receptor interaction with PIP 2 . To address this possibility, we first aimed at assessing the role of PIP 2 -interacting basic residues of the EGFR JD on receptor auto-phosphorylation, using a system appropriate for subsequent physiological studies. X. laevis oocytes provide a heterologous expression system, where ion channel function can be conveniently studied and where the EGFR has been shown to reconstitute with similar properties as in mammalian cells [29] . We used this system to express full length wild-type or mutant EGFR bearing Arg to Asn substitutions within the PIP 2 binding domain (see Fig. 2a ). An anti total EGFR antibody was used to determine levels of expression of wild-type and mutant EGFR (see Fig. 2b for its specificity), whereas an antibody that specifically recognizes phosphorylated tyrosine 992 of the EGFR (EGFR Y992 ) was used to determine basal and EGFinduced phosphorylation of wild-type and mutant EGFR ( Fig. 2c-e) . Figure 2c shows that phosphorylation at Y992 of the mutant EGFR bearing the eight Arg to Asn substitutions (ASN8) is clearly impaired, indicating that the same amino acids that are critical for the receptor/PIP 2 interaction are also critical for its auto-phosphorylation. From the other two mutants, ASN3 appeared to have the highest impact. Similar results were obtained using a general anti-phosphotyrosine antibody (4 G10; Fig. 2d) . Quantification of the data on the EGF-induced EGFR phosphorylation at Y992 from several independent experiments (n=6-8) revealed that the ASN3 mutation was almost as potent as the ASN8 in suppressing EGF-induced Y992 phosphorylation, while mutation of the five distal Arg residues (ASN5) resulted in a weaker, but statistically significant suppression of receptor phosphorylation (Fig. 2e) .
To exclude the possibility that the impaired EGFR phosphorylation seen with the ASN3 and ASN8 mutants was due to a decrease in plasma membrane localization, we compared surface expression levels of wild-type EGFR with those of EGFR bearing the ASN3 and ASN8 mutations. Online Resource Figure S1 shows that the mutations did not interfere with the surface expression of the receptor, in good agreement with previous reports showing that neither neutralization [50] , nor deletion [1] of the 645-657 region of EGFR prevented its expression at the cell surface. Together, our data indicate that neutralization of the basic amino acids between 645 and 657 residues of the EGFR JD region (a) suppressed its autophosphorylation and (b) the three most proximal to the membrane Arg residues (ASN3 or R645-R647) are the most critical for receptor phosphorylation. In agreement with these data, alanine scanning mutagenesis in a recent study by Red Brewer et al. [31] in 2009 revealed R646 and R647 as the for EGFR 645-672 4,000, 2,000, 1,000, 500, and 250, for EGFR 6 4 5 -6 7 2 M U T 500, 250, 125, 62.5, and 31.125, for EGFR 1156-1172 2,000, 1,000, 500, 250, and 125. Sensorgrams obtained from EGFR 645-672 were fitted using a 1:1 Langmuir binding model (not shown), and after subtraction from data obtained simultaneously from another channel of the same sensor chip, where no ligand had been immobilized. The data from EGFR 1156-1172 and EGFR 645-672MUT could not be fitted. At concentrations exceeding 1,000 nM, the EGFR 645-672MUT associated with the chip nonspecifically (not shown) two most critical residues in the entire 645-657 region for EGFR phosphorylation.
To investigate the effect of the above JD mutations on EGF-dependent downstream signaling, we asked whether the mutations affect EGF-dependent regulation of ion channel activity. Xenopus oocytes possess endogenous outwardly rectifying (i.e., conduct more outward than inward current at similar electrochemical driving forces) Ca 2+ -activated chloride (CaCl) channels that are activated by the Ca 2+ released from IP 3 -dependent Ca 2+ stores [46] . Electrophysiological monitoring of CaCl currents (I CaCl ) in Xenopus oocytes provides a sensitive assay of intracellular Ca 2+ and can therefore serve as a native sensor of Ca 2+ release (an alternative to Ca 2+ -sensitive dyes) that follows stimulation of PLC-coupled receptors (e.g., EGFR, M1 ACh receptors, etc.). Figure 3 shows that oocytes expressing wild-type or mutant EGFR could all elicit at positive potentials outward I CaCl when stimulated by EGF (Fig. 3a,  upper traces) , thus ensuring that the mutant EGFR could still signal downstream.
We have previously shown that PIP 2 hydrolysis through EGFR signaling inhibits the activity of both heteromeric Kir3.1/3.4 and homomeric Kir3.4* (Kir3.4-S143T) inwardly rectifying channels [17] . Inhibition of Kir3 currents provides better quantification of the relative effect of the EGFR mutations on EGF-dependent inhibition than I CaCl , possibly due to the desensitizing character of I CaCl . Thus, we used oocytes co-expressing Kir3.4* together with either wild-type or mutant EGFR. Figure 3b shows that GIRK4* currents prior to inhibition by EGF were at comparable levels of expression regardless of whether they were co-expressed with wild-type or mutant EGFR. Simultaneous monitoring of outwardly and inwardly rectifying currents enabled us to examine whether EGFR signaling took place (outward I CaCl ), while at the same time to quantify the extent of the signaling (inhibition of inward Kir3.4* currents). Figure 3a (lower traces) and (summary of data) show that the ASN5 mutant inhibited Kir3.4* currents upon EGF stimulation almost as effectively as the wild-type EGFR. In contrast, the ASN8 and ASN3 mutants, although they were still functional in eliciting I CaCl , were significantly less effective in inhibiting Kir3.4* currents upon EGF stimulation (Fig. 3a, c) .
Together, these data show that mutation of the first three Arg residues in the PIP 2 -binding region of the EGFR basic JD is enough to suppress receptor autophosphorylation and downstream signaling to ion channels, in complete agreement with the alanine scanning mutagenesis data of Red Brewer et al. [31] , reporting R646 and R647 as the two most critical residues in the 
b Western blot analysis of the membrane fraction of EGFR-expressing (EGFR) and control non-injected oocytes (NI) with anti EGFR antibodies. c Western Blot analysis of the membrane fraction of EGF-treated (+) and control (−) oocytes, expressing wild-type or mutant full-length EGFR, with anti phospho-EGFR (EGFR Y992 ) and
anti total EGFR antibodies. d Western Blot analysis of membrane extracts from EGF-treated and control oocytes, using anti phosphotyrosine (4 G10) and anti total EGFR antibodies. e Summary of the data on EGF-induced phosphorylation from six to eight independent experiments. Phospho-EGFR(Y992)/total EGFR ratios are expressed as a percentage of the respective ratio in the EGF-treated wild-type EGFR sample. *P≤0.05, **P≤0.005 entire 645-657 region for EGFR phosphorylation. Unlike the above mentioned group, however, we were not able to further narrow down the critical region, as each of the two point mutations that we tested (R645N and R646N) did not result in significant differences in EGF-induced Kir3 current inhibition when compared to wild-type EGFR (data not shown).
Functional control of EGFR phosphorylation by altering PIP 2 levels
To investigate whether PIP 2 can modulate EGFR function, we used the PI kinase inhibitor Wortmannin. Generally, Wortmannin inhibits PI(4) kinase (PI4K) at micromolar concentrations, in addition to blocking PI(3) kinase (PI3K), at nanomolar concentrations [28] . PI-4 K is a critical enzyme in the synthetic cascade of PIP 2 that catalyzes the addition of phosphate to the 4′ position of the inositol ring of PI, leading to the formation of the PIP 2 precursor PI(4)P [45] . Online resource Figure S2 shows that treatment of oocytes with 15 μM of Wortmannin for 1 h reduced PIP 2 levels to about 40% of control (see Online resource Figure S2 ). Thus, in agreement with previously published data [48] , Wortmannin can effectively reduce PIP 2 levels. Figure 4a shows a robust, progressive decrease in the EGF-induced EGFR Y992 phosphorylation elicited by increasing concentrations of Wortmannin treatment. Wortmannin treatment (100 nM or 15 μM for one hour) reduced EGFR Y992 phosphorylation three-and sixfold, respectively (Fig. 4b) , whereas the amounts of EGFR present, probed with an anti-total EGFR antibody were not significantly different. A similar inhibition of EGFR phosphorylation was observed when we probed phosphotyrosine at position 1045 (data not shown). Since low concentrations of Wortmannin mainly affect PI-3 K rather than PI4K, the threefold reduction observed with 100 nM of Wortmannin implies a possible contribution of PIP 3 . This may be specific to the oocyte system, since 100 nM of Wortmannin was ineffective in suppressing EGFR phosphorylation in HeLa cells (see Fig. 5a, b) . Even in oocytes however, the additional reduction of EGFR phosphorylation observed upon treatment with 15 μM of Wortmannin (a concentration that reduces PIP 2 levels to about 40% of control, see Online Resource Figure S2 ), suggests that EGFR activation depends on PIP 2 . Consistent with this hypothesis, earlier work has shown that both PI4K and PIP5K interact with the EGFR [4] . To further test our hypothesis, we employed synaptojanin, a protein that has also been shown to interact with the EGFR, and whose constitutive PIP 2 5-phosphatase activity hydrolyzes PIP 2 to PI(4)P [36] . Introduction of synaptojanin mRNA in oocytes decreased EGFR Y992 phosphorylation (Fig. 4c, d) , further supporting the correlation between decreased PIP 2 and inhibition of EGFR phosphorylation. If decreases in PIP 2 levels result in diminished EGFR phosphorylation, then an increase in PIP 2 levels would be expected to have the opposite effect. Indeed, overexpression of PIP5KIα (a final enzyme in the pathway that leads to PIP 2 formation), produced a significant gain in the phosphorylation of wild-type EGFR (Fig. 4e, f) . Importantly, phosphorylation of the ASN8 mutant (which does not bind PIP 2 , see Fig. 1 , EGFR 645-662MUT ) was not affected by PI(5)PKIα overexpression (Fig. 4e, f , see ASN8±PIP5KIα). These findings further support the notion that EGFR activation depends on the levels of PIP 2 .
To test whether the observed effect of PIP 2 on autophosphorylation of heterologously expressed EGFR also applies to mammalian cells with native EGFRs, we used HeLa cells, a cell line of mammalian origin that expresses EGFR endogenously. Figure 5a and b show that EGFinduced phosphorylation of Y992 in the endogenous EGFR of HeLa cells was not significantly affected by 100 nM Wortmannin (overnight application in parallel with serum starvation), but was significantly inhibited by 15-μM Wortmannin.
RNA interference was used to down-regulate the levels of the lipid kinase PIP5KIα, in order to suppress production of PIP 2 . This treatment indeed led to a significant reduction in the levels of PIP5KIα (Fig. 5c, d ), whereas levels of β- analysis of membrane extracts from EGF-treated oocytes expressing EGFR±synaptojanin. d Mean EGF-induced EGFR Y992 phosphorylation was calculated from three experiments and expressed as %±SE of phosphorylation of control (t test, p<0.01). e, f Co-expression of PIPKIα potentiates EGF-induced phosphorylation of wild-type, but not ASN8 mutant EGFR. e Western blot analysis of membrane extracts from EGF-treated oocytes expressing wild-type or ASN8 mutant EGFR±PIPKIα. f Mean EGF-induced EGFR Y992 phosphorylation was calculated from three experiments and expressed as %±SE of phosphorylation of control (t test, p<0.05) tubulin were not affected (see Fig. 5c ). Interestingly, HeLa cells transfected with the siRNA for PIP5KIα displayed a marked reduction in both their basal (which was high enough in three out of four batches of cells to allow detection by WB), and EGF-induced EGFR Y992 phosphorylation ( Fig. 5e and f) . The suppression of basal EGFR phosphorylation by PIP5KIα siRNA implies that spontaneous autophosphorylation of the receptor may also be sensitive to PIP 2 . Alternatively, despite the overnight starvation, depletion of growth factors may not be complete and therefore what is referred to as basal phopshorylation most probably reflects, at least in part, the contribution of residual EGF-induced phosphorylation, which is sensitive to PIP 2 .
Since it has been reported that it is the PIP5KIβ and not the PIP5KIα isoform that is involved in EGFR internalization, it is unlikely that the siRNA-mediated reduction of the PIP5KIα isoform led to a decrease in EGFR autophosphorylation due to a decreased cell surface receptor density. To explicitly control for such a possibility, we subjected HeLa cells to FACS analysis to determine the cell surface receptor density before and after treatment with siRNA for the PIP5KIα isoform. EGF stimulation indeed caused a reduction in the cell surface receptor density, as has been previously shown [41] . However, treatment with siRNA for the PIP5KIα isoform had no effect on cell surface receptor density before or after EGF treatment (see Online resource Figure S3) . Thus, the effect of the siRNA of the PIP5KIα isoform on autophosphorylation of EGFR was not due to changes in receptor internalization.
Discussion
Phosphoinositides, and in particular phosphatidylinositol (4,5)-bisphosphate, are emerging as central regulators of diverse cellular functions through their effects on transmembrane or plasma membrane associated proteins. Among the best examples of PIP 2 -sensitive proteins are a long list of ion channels, the activity of which depends on their association [18, 42] , and the myristoylated alanine-rich C kinase substrate (MARCKS), which acts as a PIP 2 buffer to regulate the availability of PIP 2 [10, 30] . Data from the present study place EGFR among the PIP 2 -dependent/PIP 2 -associated proteins. Pharmacological or genetic downregulation of PIP 2 levels severely impaired EGFR activation, as measured by receptor auto-phosphorylation, whereas up-regulation of PIP 2 potentiated EGF-mediated activation of the receptor.
Our data suggest that specific positively charged residues at the N terminus of the basic juxtamembrane domain of EGFR (645-657) are responsible for receptor interaction with PIP 2 . Mutation of positively charged residues to neutral ones abolished EGFR/PIP 2 interactions and drastically down-regulated receptor activation and signaling to ion channels. Further mutations helped us narrow the critical region to the first three residues of the basic cluster (R645, R646, and R647) as the most critical for receptor activation. In agreement with this conclusion, alanine scanning mutagenesis in a recent study by Red Brewer et al. [31] revealed R646A and R647A as the two most potent mutations in the entire 645-657 region in terms of suppressing EGFR phosphorylation. With regards to downstream signaling however, although the ASN3 mutation (R645N+R646N+R647N) in our study abolished EGFRmediated inhibition of Kir3.4* currents, the R645N and R646N single point mutants were not effective.
Several previous reports have highlighted the importance of the EGFR juxtamembrane domain and in particular the 645-657 JM region, on the regulation of receptor activation. Both positive and negative regulatory roles on EGFR activation have been attributed to this region. The inhibitory effects have been attributed to PKC-mediated phosphorylation of Thr-654 at the juxtamembrane region of the EGFR [22, 37] , whereas the entire 645-657 region appears to be indispensable for EGFR activation. Deletion of this region has been shown to result in loss of receptor dimerization and trans-autophoshorylation [1, 15, 44] , whereas neutralization of the positively charged residue (Arg/Lys to Asn) mutations (the exact same mutations that abolish PIP 2 binding, see Fig. 1 ), severely down-regulated receptor phosphorylation in both NIH3T3 and NR6 cells [50] . Our data suggest that the PIP 2 -interacting characteristic of the 645-657 region is key to the indispensable role of this region for EGFR activation.
Association of the JM domain of EGFR with PIP 2 has previously been shown [25] and it has been interpreted as a mechanism serving to keep the receptor in an inactive state, when not bound to the ligand [25] . According to the proposed model, upon ligand binding, and receptor dimerization, spontaneous dissociation of a small fraction of the receptors from the membrane could lead to a low level auto-phosphorylation, activation of PLC, IP 3 -mediated calcium release with a subsequent recruitment of Ca/CaM to the JM domain of the EGFR. This Ca/CaM binding on EGFR would reverse the charge of the juxtamembrane domain, resulting in disengagement of the whole cytoplasmic domain of the receptor from the membrane and exposing the Receptor Tyrosine Kinase domain to phosphorylation and full activation of the receptor. Such a model predicts that prevention of EGFR/PIP 2 interaction would favor ligand-independent activation of EGFR and potentiate its EGF-mediated activation [25] . However, as discussed in more detail in [39] , despite this prediction, mutations in the juxtamembrane domain of EGFR that prevent PIP 2 binding inactivate the receptor ([50] and the current study). Since the proposed calmodulin-dependent EGFR regulation requires some level of receptor activation and downstream Ca 2+ release [25] , it is reasonable to hypothesize that this may be occurring at a step downstream of the PIP 2 -dependent regulation that was revealed in the present study.
The precise mechanism of action of PIP 2 on the EGFR is unknown. A crystal structure of the EGFR kinase domain by Zhang et al. [53] shows the formation of an asymmetric dimer between receptor monomers in the activated state. Even though the structure does not include the JD, the authors state that the positioning, flexibility and possible movements of the JD are important, especially since there seems to be a gap between the ends of the dimeric extracellular region (∼20 Å apart) and the N-terminal residues of the two kinase monomers (∼50 Å apart) [53] . A recent crystal structure by Red Brewer et al. [31] , which includes the JD, confirms the asymmetric dimer between receptor monomers and nearly all of the donor acceptor interactions seen in the previous structure. Similar were the conclusions from another recent study by Jura et al. [15] who again show that the membrane distal segment of the juxtamembrane region of the receiver/acceptor kinase makes stabilizing contacts with the C-terminal lobe of the activator/donor kinase and propose a model according to which, the membrane-proximal segment of the juxtamembrane region of EGFR (645-663) forms an antiparallel helical dimer that engages the transmembrane helices of the activated receptor to facilitate formation of the asymmetric kinase dimer. The impairment in EGFR activation by the mutations employed in our study most likely reflects both inhibition of PIP 2 binding and prevention of asymmetric contact formation. The proposal by Jura et al. activating JD latch resembles the case of erbB2 in which, the transmembrane domains are involved in a rotational sliding of the two monomeric helices against each other to regulate dimerization [9] . Because the JD connects the kinase lobes to the transmembrane segments, such facts point to the JD, which can bind PIP 2 , as an important regulator of EGFR activation. Thus, the EGFR JD with the aid of PIP 2 may have a role similar to the JD segments of the FLT3 receptor tyrosine kinase, i.e., to correctly align and maintain proper register during transition states [11] .
It is well established that receptor-induced PLC activation and PIP 2 hydrolysis underlie receptor-mediated inhibition of ion channel activity [16, 17, 52] . Spatiotemporal regulation of PIP 2 levels may serve to provide the cell with the appropriate flexibility to fine-tune certain signaling pathways. For example although PIP 2 is required for NMDA receptor activity [26] , NMDAR-mediated PLC hydrolysis of PIP 2 is necessary for spine remodeling and AMPAR internalization during NMDA receptor-dependent LTD [12] and mice lacking PLCβ1, the predominant PLC isoform in the forebrain, are LTD deficient [2] . In the case of EGFR, in view of our data showing its dependence on PIP 2 for full activation and transmission of EGF-dependent signal, the EGFR-dependent PLC activation and PIP 2 hydrolysis may serve as a negative feedback loop to promote receptor inactivation after transmission of the signal to downstream effectors. This auto-inhibitory loop would serve to terminate EGFR-mediated activation of PLC, thus preventing over-depletion of PIP 2 due to sustained PLC activity. Consequently, the newly formed PIP 2 would be allowed to establish the appropriate environment for a new cycle of EGFR activation.
